Author

F. Lardon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:imaging· 1 Assay:organoid / primary culture· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Lin· 2 shared C. Deben· 2 shared E. Smits· 2 shared M. Le Compte· 2 shared S. Van Laere· 2 shared S. Vanlanduit· 2 shared A. Bogaerts· 1 shared A. Domen· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Lin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Uncovering the hidden threat: single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer

M. Le Compte, E. Cardenas De La Hoz, S. Peeters, F. Rodrigues Fortes, C. Hermans, A. Domen, E. Smits, F. Lardon, T. Vandamme, A. Lin, S. Vanlanduit, G. Roeyen, S. Van Laere, H. Prenen, M. Peeters, C. Deben

This study uses single-organoid analysis to identify treatment-resistant and invasive subclones in pancreatic cancer, correlating with patient outcomes and drug response.

bioRxiv · Feb 27, 2023 · PreprintCancer Biology

OrBITS: A High-throughput, time-lapse, and label-free drug screening platform for patient-derived 3D organoids

C. Deben, E. C. De La Hoz, M. Le Compte, P. Van Schil, J. M. Hendriks, P. Lauwers, S. K. Yogeswaran, F. Lardon, S. Van Laere, P. Pauwels, A. Bogaerts, E. Smits, S. Vanlanduit, A. Lin

The paper introduces OrBITS, a software for automated live-cell imaging of organoids, validated against standard assays, and demonstrates its utility in drug screening and patient stratification.

bioRxiv · Sep 9, 2021 · PreprintCancer Biology